IHC assays of stomach cancer tissues also showed that SRGN was mainly expressed in tumour cells (Fig. 3d), and CD44 tended to be expressed in CAFs and some lymphocytes (Fig. 4e). This evidence concerns the gene CD44 and gastric neoplasm.